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Tissue adhesives have emerged as an alternative to sutures and staples for wound closure
and reconnection of injured tissues after surgery or trauma. Owing to their convenience and
effectiveness, these adhesives have received growing attention particularly in minimally
invasive procedures. For safe and accurate applications, tissue adhesives should be detectable
via clinical imaging modalities and be highly biocompatible for intracorporeal procedures.
However, few adhesives meet all these requirements. Herein, we show that biocompatible
tantalum oxide/silica core/shell nanoparticles (TSNs) exhibit not only high contrast effects
for real-time imaging but also strong adhesive properties. Furthermore, the biocompatible
TSNs cause much less cellular toxicity and less inflammation than a clinically used, imageable
tissue adhesive (that is, a mixture of cyanoacrylate and Lipiodol). Because of their multi-
functional imaging and adhesive property, the TSNs are successfully applied as a hemostatic
adhesive for minimally invasive procedures and as an immobilized marker for image-guided
procedures.
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T
issue adhesives have various advantages over sutures and
staples, including a simpler implementation procedure,
more immediate sealing, less pain to patients, lower
infection rates, and less trauma on operated tissues1–4.
Hence, their clinical demands have grown significantly, and
consequently, a number of tissue adhesives based on proteins and
synthetic polymers including fibrin, gelatin, polyurethanes,
and polyethylene glycol have been developed to accommodate
various surgical situations5–10. The convenience of tissue
adhesives is particularly noticeable in minimally invasive
procedures and image-guided surgeries because they are very
effective for treating a confined region of interest that is
inaccessible with other wound closure methods, which can
greatly reduce postoperative complications. Since minimally
invasive procedures are typically guided by real-time imaging
modalities, such as X-ray fluoroscopy, computed tomography
(CT), ultrasonography, and fluorescence imaging, it is useful that
the applied tissue adhesives are visible with such imaging
modalities for accurate and safe applications11–13. Moreover,
radiotherapy or minimally invasive procedures to soft organs can
also be aided by the tissue adhesives with imaging contrast effects
for efficient recognition and follow-up of the target areas along
the physiological movement of the organ14,15.
Nanoparticles have been incorporated with tissue adhesives
or hydrogels to enhance their mechanical properties, adhesive
strength and electrical conductivity and to provide unique
functions such as antibacterial effects4,16–18. Recently, it was
reported that the nanoparticle solution itself can act as an
adhesive for hydrogels and biological tissues19. Owing to its large
surface area and the high adsorption energy between biological
tissues and the nanoparticle surface, the adhesive property of
nanoparticles is sufficient for various applications, such as
hemostasis, wound closure, and scaffold-attachments20. On the
other hand, nanoparticles have also been employed as biomedical
imaging probes owing to their unique physical properties and
capability of conjugating functional moieties via surface
modification21–29. They have been used with various molecular
imaging modalities for the sensitive diagnosis of lesions30–37.
On the basis of these two different medical applications of
nanoparticles, they may be a promising candidate for multimodal
image-guided procedures38–40. Herein, we design core-shell
structured tantalum oxide-silica nanoparticles as tissue
adhesives in image-guided surgery.
Results
Designed synthesis and characterization of TSNs. We employ
silica (SiO2) as the shell material to endow the nanoparticles with
a tissue adhesive property, because its surface offers high adhesive
strength to hydrogels or tissues19. Radiopaque tantalum oxide
(TaOx) is selected as the core material to provide contrast
enhancement on X-ray fluoroscopy and CT (Fig. 1a)41–44. TaOx
nanoparticles combined with various organic and inorganic
moieties have been applied to multimodal imaging
and/or theranostics29,45–47. In the current study, the high
density of the TaOx core and the facile modification of the SiO2
surface allow for ultrasound (US) and fluorescence imaging.
As designed, the TaOx/SiO2 core/shell nanoparticle (TSN)
glue is clearly visualized by real-time imaging modalities,
which facilitates image-guided, less-invasive procedures using
this material, and exhibits adhesive property similar to that of a
mixture of cyanoacrylate and Lipiodol (CA-Lp) used in clinical
practice (Fig. 1b). Cyanoacrylate adhesive, a frequently used tissue
adhesive in human, has to be mixed with radiopaque iodized oil
(Lipiodol) to be administered under the guidance of fluoroscopy.
Moreover, compared to the clinically used CA-Lp, TSNs are
highly biocompatible, as evidenced by dramatically reduced
cytotoxicity and inflammation reaction. We also demonstrate that
TSNs can work as tissue adhesives with the assistance of
multimodal imaging modalities in a liver puncture model to
stop internal bleeding. Because of their adhesive property and
multimodal imaging capability, TSNs are used as an injectable
immobilized anatomical marker to aid image-guided surgery.
TSNs were synthesized by the sol-gel reaction of tantalum(V)
ethoxide in nanometer-sized microemulsion41. After TaOx
nanoparticles were generated, the SiO2 shell was grown on the
TaOx core by sol-gel reaction of tetraethoxysilane (TEOS). High-
angle annular dark-field scanning transmission electron
microscopy (HAADF-STEM) images show uniform
nanoparticles of an overall size of 8.5±0.8 nm with a SiO2 shell
thickness of 1.3±0.2 nm (Fig. 1c). Shell thickness is easily
controllable from 1 to 5 nm by changing the amount of TEOS
added (Supplementary Fig. 1). Electron energy loss spectroscopy
(EELS) mapping, energy-dispersive X-ray spectroscopy (EDS)
mapping, and EDS line scanning show overlapped signals from
tantalum and silicon elements, suggesting a core-shell structure
(Fig. 1d–f, Supplementary Figs 1 and 2). The core/shell structure
is also confirmed by the contrast difference between TaOx and
SiO2 in the TEM images of TSNs with varying SiO2 shell
thickness (Supplementary Fig. 3). It is also noteworthy that no
separate formation of either silica or tantalum oxide nanoparticles
occurred. After the nanoparticles were purified by centrifugation,
they were treated with acid to remove any residual adsorbed
surfactants that may interfere with the interactions between
the nanoparticle surface and biological tissues, leading to the loss
of the adhesive property. Removal of the surfactants was
confirmed with Fourier transform infrared spectroscopy by the
disappearance of peaks related to Igepal CO-520 (Supplementary
Fig. 4a). Without the SiO2 shell, the reactive TaOx surface causes
a severe aggregation of tantalum oxide nanoparticles after the
removal of surfactants (Supplementary Fig. 4b), generating
micrometer-sized agglomerates (Supplementary Fig. 4b,f).
However, the SiO2 shell successfully protects TSNs from
irreversible agglomeration, resulting in the number-average
hydrodynamic diameter of 20.4 nm (Supplementary Fig. 4g). It
is crucial that the TSNs should be well dispersed as nanoparticle
form because the adhesive property of the nanoparticles is
affected by surface adsorption with biological tissue, which will be
discussed below. To utilize TSNs for optical image-guided
surgery, fluorescent TSNs were prepared by covalent
attachment of tetramethylrhodamine isothiocyanate (TRITC)
onto the TSN surface. Photoluminescence of the TRITC-
conjugated TSNs reveals a typical peak of TRITC at 576 nm
(Supplementary Fig. 3l).
Tissue adhesive property and hemostatic capability. To evaluate
the suitability of the TSNs for image-guided procedures, their
adhesive property was examined with internal tissues containing
biological fluids. Liver is an appropriate substrate because it
contains abundant biological fluid and blood vessels which have
to be sealed inside and it has rather uniform structures among
the internal organs. The tissue adhesive property of TSNs was
evaluated using a lap joint shear test of liver ribbons. Two liver
ribbons were adhered together by gently pressing with a fingertip
after spreading 15 ml of the glue solutions (TSNs, SiO2
nanoparticles (SiO2 NPs), TaOx NPs, CA-Lp, and TSNs coated
with Igepal CO-520). Here, CA-Lp was used as a positive
control group because it is a U.S. Food and Drug Administration
(FDA)-approved tissue adhesive form with a contrast effect and
one of the most commonly used glue in image-guided procedures
for human. When the upper ribbon was lifted with forceps, it held
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the lower ribbon without slipping (Fig. 2a). Force-displacement
curves were obtained using a universal test machine (UTM) as
shown in Fig. 2b. To account for the large deviation of failure
forces due to tissue heterogeneity, nine samples were measured
for each type of glue (Fig. 2c and Supplementary Fig. 5). The
adhesive strengths of all applied adhesives exceeded the intrinsic
adhesion strength of biological tissues (Supplementary Fig. 5b).
TSNs exhibit an adhesion strength comparable to that of
CA-Lp (1:3) mixture that has enough contrast effect to be
visualized in X-ray fluoroscopy (Supplementary Fig. 6). SiO2 NP
solution also shows similar strength with that of CA-Lp and
TSNs. Although the TSNs show much lower adhesion strength
than that of commercial CA, the CA is not detectable in
X-ray imaging modalities, and unable to be used by itself in
image-guided procedures.
To determine the optimal concentration of TSN for adhesive
properties, the adhesive strengths were measured with various
TSN concentrations. Because the adhesive force increases with
increasing nanoparticle concentration (Supplementary Fig. 7), the
highest 40 wt% TSN solution was used for hemostasis or markers.
The force-displacement curves of TSNs (Supplementary
Fig. 5a) show a similar pattern to that of SiO2 NPs, indicating
that the adhesion characteristics of TSNs originate from
nanoparticle adsorption onto the biological tissue surface and
corresponding energy dissipation from the hydrogel-like soft
tissues, as previously proposed19.
Gluing biological tissues with nanoparticles mainly depends
on the ability of nanoparticles to adsorb onto tissues, which
involves the interaction between the nanoparticle surface and
biological molecules on tissues19,48. To investigate the adhesive
mechanism of TSNs, we prepared various types of TSNs that are
surface-functionalized with primary amine, carboxylate, and
polyethylene oxide group (Supplementary Table 1 and
Supplementary Fig. 8). All of these surface grafted TSNs exhibit
no adhesive property (Supplementary Fig. 9). On the other hand,
TSNs covered with Igepal CO-520 show fourfold reduced
adhesive property than that of bare TSNs that are obtained by
the complete removal of Igepal CO-520 by the acid treatment
(Supplementary Fig. 9). Meanwhile, agglomeration of TaOx NPs
leads to the decrease of adhesion strength by half compared with
TSNs (Fig. 2c and Supplementary Fig. 5). These results clearly
demonstrate that the silica surface is mainly responsible for the
adhesive property of TSNs. Furthermore, silica coating imparts
colloidal stability of TSNs.
Adsorption of TSNs was investigated using scanning electron
microscopy (SEM) and TEM. SEM and TEM images of the liver
samples show localization of TSNs near hepatocytes and leaked
subcellular vesicles from the damaged cells by the adsorption of
TSNs near lipid layer (Supplementary Fig. 10). Moreover,
entangling and adsorption interactions between fibrin fibers and
TSNs confirm that the adsorption and spontaneous network
formation of TSNs on biological tissues enables the adhesion of
cut liver tissues (Fig. 2d and Supplementary Fig. 10).
After confirming their adhesive property, TSNs were applied to
hemostasis in a liver puncture model. Since it is difficult to suture
a highly vascularized liver wound, either tissue adhesives or
sealants are necessary for the warranted closure of hepatic
wounds. Puncture injuries were prepared by making a track with
a sterile 18-guage needle in the livers of Sprague-Dawley (SD)

























Figure 1 | Design and multifunctionality of TSNs. (a) Schematic illustration of a multifunctional Tantalum oxide/silica core/shell nanoparticles (TSNs)
with a radiopaque core for X-ray imaging, conjugated fluorescent dye for fluorescent imaging, a dense core material with a high sound-scattering effect for
ultrasound imaging, and a silica surface for adhesive property. (b) Representative images demonstrating multifunctionality of TSNs, and high-resolution
transmission electron microscope image of TSN in center. Dashed lines indicate boundaries of core and shell of the nanoparticle. Scale bar indicates 5 nm.
(c) High angle annular dark field scanning transmission electron microscope image of TSNs. Scale bar indicates 5 nm. (d–f) Elemental mapping images of
tantalum (Ta) (d), silicon (Si) (e) and their merged image (f) obtained by electron energy loss spectroscopy. Scale bar, 10 nm.
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applied to each track as a hemostatic agent, or direct pressure was
put onto the stab wound as a control. Because it is almost
impossible to impose pressure in a minimally invasive procedure,
no pressure was applied at the sites where the adhesives were
treated. As shown in Fig. 2e, both TSNs and CA-Lp successfully
stopped bleeding immediately after their application. However,
severe blood loss occurred in the control without any adhesives,
even though direct pressure was exerted. The amount of bleeding
was measured by the weight difference of a filter paper before and
after absorbing the blood (Supplementary Fig. 11). A significant
decrease in the amount of blood was observed when TSNs, SiO2
NPs or CA-Lp was applied, and their hemostatic effects were
similar (Fig. 2f).
Contrast enhancement in various medical modalities. The
contrast effects of TSNs on fluoroscopy, CT and ultrasonography
were compared to those of SiO2 NPs, CA-Lp, and a commercially
available iodine contrast agent (iopamidol). Since X-ray
absorption of the contrast agents results in signal attenuation on
fluoroscopy, their contrast effects were assessed by signal-to-noise
ratios (SNR) (Fig. 3a). The X-ray fluoroscopic image reveals that
TSNs significantly attenuate incident X-ray beam, showing a
contrast efficiency comparable to that of iodine-containing
CA-Lp. The SNR of TSNs is 15 times higher than that of SiO2
NPs, demonstrating that the TaOx core is responsible for the high
X-ray attenuation31,41. To evaluate the detection limit of TSNs on
CT, we compared the CT numbers (Hounsfield unit, HU) of
serially diluted solutions with different TSN concentrations
(Supplementary Fig. 12a,d). The contrast effect increases
linearly as the concentration increases, and both TSNs and
iopamidol are distinguishable from water down to a
concentration of 12.5 mg ml 1. The contrast efficiencies of
TSNs and iopamidol, calculated from the slopes of X-ray
fluoroscopy SNR versus concentration, are 0.18 mg 1 ml and
0.17 mg 1 ml, respectively, while SiO2 NPs exhibit a negligible
contrast enhancement effect (1.8 10 4 mg 1 ml). The CT
contrast enhancement effect of TSNs was also evaluated by the
slope of CT number versus concentration and compared with
those of iopamidol and SiO2 NPs. The contrast enhancement of
TSNs is 18.6 HU mg 1 ml, which is 1.5 and 150 times higher
than those of CA-Lp (12.9 HU mg 1 ml) and SiO2 NPs
(0.12 HU mg 1 ml), respectively (Fig. 3b, and Supplementary
Fig. 12b,e). The stronger contrast effect of TSNs in CT can be
attributed to the higher X-ray photon energy used in CT (applied
voltage is 140 kV) compared to that used in fluoroscopy (60 kV),
and the well-matched K-edge value of tantalum (67.4 keV)
compared with that of iodine (33.2 keV)31.
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Figure 2 | Adhesion strength and hemostatic effect of TSNs in a liver puncture model. (a) Photographs showing the lap joint preparation procedure for
analysing adhesive strength of various glues on biological tissues of two calf liver ribbons: applying the adhesive, attaching by overlapping the ribbons at the
region where the adhesive was applied, gently pressing the ribbon for 30 s, and lifting up and moving the joint to be analysed. (b) Photographs showing the
lap joint shear test, and a representative force-displacement curve of the lap joint shear test of liver ribbons adhered by TSNs: (i) lifting the lower ribbon,
(ii) loading the stress, (iii) ultimate stress point and failure, and (iv) sliding. (c) Adhesive shear stress of lap joint attached without glue (control) or with
CA-Lp, SiO2 NPs, TaOx NPs and TSNs. (Data are shown as mean±s.d., n¼ 9, *Po0.05, ****Po0.0001, and NS, not significant P40.05, one-way ANOVA
test.) (d) Scanning electron microscopy (SEM) image showing the adsorbing and entangling interaction between fibrin fibers and TSNs. TSNs and fibrin
fiber are highlighted blue and yellow, respectively. Scale bar indicates 500 nm. (e) Photographs of a stab wound after conducting each hemostasis
procedure: direct pressure (left), applying TSNs (right). (f) Amount of bleeding during each hemostasis procedure. (Data are shown as mean±s.d., n¼ 5,
*Po0.05, NS, not significant P40.05, one-way ANOVA test.)
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The high mass density of TSNs compared with that of water
and flesh offers an effective scattering of US-waves, allowing for
the use of TSNs in ultrasonography-guided procedures. The
contrast enhancements of TSNs and SiO2 NPs were investigated
using an agarose phantom loaded with different concentrations of
the nanoparticles (Fig. 3c and Supplementary Fig. 12c,f). The US
signal of TSNs is distinguishable from the background starting
from a nanoparticle concentration of 8 mg ml 1, and the signal
enhancement of TSNs is three times higher than that of SiO2 NPs.
It is well known that the back-scattered US generated from
Rayleigh scattering is affected by the material size, compressibility
and density difference from environment49. Therefore, not only a
larger hydrodynamic size of TSNs (20.4 nm) than that of
SiO2 NPs (16.4 nm) but also a high density of the TaOx core
(B8.18 g cm 3) contributed to the more intense US signals in
comparison to those of SiO2 NPs, enabling a much lower
detection limit (Supplementary Fig. 4).
The in vivo contrast enhancement of TSNs in different imaging
modalities was assessed using the aforementioned liver puncture
model. As the contrast effects of TSNs and CA-Lp on fluoroscopy
are similar, the liver columns filled with each glue exhibit almost
identical contrast in the fluoroscope images (Fig. 3d). Notably,
the glues are clearly distinguished from the ribs with a similar
thickness, which can be advantageous in clinical situations.
Similarly, CT imaging reveals that the mean HU value of TSNs is
1.8 times greater than that of the vertebrae and slightly higher
than that of CA-Lp (Fig. 3e). Since it is hard to compare directly
the contrast enhancements on ultrasonography in a rat due to the
small size of its liver, the contrast enhancement of TSNs, CA-Lp,
and SiO2 NPs was investigated using the calf liver injected with
each glue at a depth of 4 cm. The bright mode (B-mode)
ultrasonography imaging shows that the signals from SiO2 NPs
and TSNs are bright enough to be distinguished from the
background liver tissue. Although the reflection of US waves from
the CA-Lp applied tissue could be detected, its difference from
background is insignificant (Fig. 3f).
Biocompatibility. One of the major hurdles for intracorporeal
use of CA-Lp is its severe toxicity and the inflammatory reactions
caused by the by-products of CA-Lp such as formaldehyde5,50,51.
Recent reports, however, have shown that both SiO2 and TaOx
nanoparticles are highly biocompatible23,27,41,52,53. Moreover,
tantalum-based stents and implants, and tantalum powder-
containing embolic materials (Onyx; Covidien, Irvine, CA) are
frequently used in clinics thanks to their biocompatibility54.
To ensure the biocompatibility of TSNs, their cytotoxicity was
evaluated using cell morphology analysis and viability assays.
To mimic in vivo glue application conditions, a small drop of
glue-gel was placed at the bottom center of a culture dish, on
which a cell suspension was added. After 24 h, most of the cells
incubated with the TSNs were attached to the plate surface
regardless of their distance from the gel, while the cells near










TSN concentration (mg ml–1)







































































Figure 3 | Contrast enhancement of TSNs on various imaging modalities in vitro and in vivo. (a) Contrast enhancement on X-ray fluoroscopy.
Fluoroscope image of the tubes containing water (Ref.), commercial silica nanoparticle solution (SiO2 NPs, 50 wt%), mixture of cyanoacrylate adhesive and
iodized oil (CA-Lp, 75% of Lipiodol, 360 mg ml 1 of iodine), and TSNs (40 wt%), and bar plot of the calculated signal to noise ratio from the image). (b)
Contrast enhancement on computed tomography (CT). CT image of microtubes containing serially diluted TSNs, and line graph of CT contrast
enhancement of SiO2 NPs, contrast agent (iopamidol), and TSNs against their concentrations. (c) Contrast enhancement on ultrasonography.
Ultrasonography images of TSN phantoms, and a plot of the mean intensities with s.d. of TSNs and SiO2 NPs against their concentrations. (d,e) In vivo
images of a Sprague Dawley (SD) rat after application of TSNs and CA-Lp on fluoroscopy (d) and CT (e). On the CT image (e), the mean CT values
(Hounsfield unit, HU) of each region of interest (TSN, CA-Lp, and bone) were measured. (f) Ultrasonography images of the calf liver where SiO2 NPs, CA-
Lp and TSNs were injected. Scale bars in d–f indicate 2 cm.
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Figure 4 | Evaluation of in vitro and in vivo biocompatibility of TSNs. (a) Cellular morphology of mammalian cells (HeLa cell line) incubated with TSNs or
CA-Lp. Scale bar indicates 200mm. (b) Viability of cells treated with TSNs, SiO2 NPs, and CA-Lp. (Data are shown as mean±s.d., n¼ 3, *Po0.05,
**Po0.01, ***Po0.001, two-way ANOVA test.) (c) Concentration-dependent hemolysis rate of TSNs, SiO2 NPs, and TSN-5 with 5 nm-thick silica. (Data
are shown as mean±s.d., n¼ 3, *Po0.001, two-way ANOVA test.) (d) Histological analyses for biocompatibility of CA-Lp and TSN. Rat livers were
explanted 3 and 14 days after the hemostasis of a puncture model, and the puncture site and adjacent liver tissue were stained with hematoxylin and eosin
(H&E). At both 3 and 14 days after TSN injection, the immune cells (purple dots) were scarcely recruited while numerous immune cells accumulated
around the puncture site and in the sinusoids among the hepatocytes (H) at both 3 and 14 days after CA-Lp injection. Scale bar indicates 100mm.
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shape (Fig. 4a). Methylthiazole tetrazolium (MTT) assay shows
that the viability of the cells incubated with CA-Lp decreases in a
dose-dependent manner while those cells incubated with TSNs
exhibit little cytotoxicity up to a concentration of 800mg ml 1,
demonstrating excellent biocompatibility of TSNs (Fig. 4b). SiO2
NPs have a lower cytotoxicity than CA-Lp, but they still show a
significant cytotoxicity at a high concentration of 800mg ml 1.
Since SiO2 NPs are known to induce hemolysis, the hemolysis
effects of TSNs were investigated55,56. As shown in Fig. 4c, most
of the red blood cells were lysed at a SiO2 NP concentration of
100mg ml 1, but the hemolysis rate by TSNs was much lower.
Because both TSNs and SiO2 NPs have similar silica structure,
the observed difference in their hemolytic effect is unexpected.
To understand the difference of their hemolysis effect, we
evaluated the influence of the nanoparticle size, the amount of
fluorescent dye, and the thickness of silica shell on hemolysis rate.
Hemolysis rate of silica nanoparticles with sizes of 22, 30, and
105 nm reveals that the largest 105 nm-sized NPs exhibit lower
hemolysis rate than that of the 22 nm- and 30 nm-sized silica
nanoparticles (Supplementary Fig. 13c), which is consistent with
the previous report55. The amount of incorporated dye does not



















































Figure 5 | In vivo applications of TSNs in multimodal image-guided procedures. (a–d) TSN adhesive for an incision-free surgical procedure in a rabbit
liver puncture model, assisted by simultaneous real-time fluoroscopy and ultrasonography. (a) Schematic drawing of the minimally invasive procedures that
consist of puncture and closing under two real-time imaging modalities. (b) The incision-free image-guided procedure. A photograph showing the sealing
process of a liver puncture track by injecting TSNs contained in a syringe. Still images of fluoroscopic video (c) and ultrasonography (d) during the track
sealing with TSNs. Blue dashed circles and red dashed rectangle indicate TSN adhesive and needles, respectively. (e,f) Mobility evaluation of fiducial
markers. (e) Top view CT images of the implanted markers before and after 10 h shaking. Black arrows indicate needle tips, and dashed circles indicate
the markers, TSNs (blue), gold rod (green), metal coil (cyan), Lipiodol (magenta), and CA-Lp (red) in the liver. (f) Average migration distances of the
markers in the liver. (Data are shown as mean±s.d. n¼ 3, *Po0.05, ***Po0.001 compared to needle-tip, two-way ANOVA test.) (g–j) Multimodal
imaging of the TSNs as an injectable fiducial marker implanted to the calf muscles of a SD rat. (g) Transversal micro-CT image showing the location of TSNs
near the fibula (calf bone). (h) Fluoroscopic image of the implanted TSNs along with the fibula. (i) Fluorescent weighted image of the same region.
(j) A series of still cuts of fluoroscopic video showing that TSN markers follow during extension and flexion movement of leg. (Blue arrows indicate the
TSN markers, and the numbers on figure (j) represent the time of each frame.) (k–m) Multimodal imaging of the percutaneously injectable TSN marker in
rat lung cancer. (k) Axial image of CT. (l) Lateral view on fluoroscopy. (m) Fluorescence imaging after thoracostomy (Blue arrows indicate the TSNs marked
in lung cancer.).
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Fig. 13d–f). Most strikingly, TSN-5 with 5 nm-thick silica shell
show much higher hemolysis rate than TSNs with 1 nm-thick
silica shell and TaOx NPs without silica shell (Supplementary
Fig. 13h).
In the previous reports, hemolysis by silica nanoparticles
was attributed to the direct interaction between the cell
membrane and silanol groups on the nanoparticle surface,
and the mesoporous silica nanoparticles are known to exhibit
lower hemolytic effect than dense silica nanoparticles55,56. The
microporous structure of TSNs seems to be responsible for their
lower hemolysis rate compared to that of the dense silica
nanoparticles (see the gas adsorption data in Supplementary
Fig. 14).
In vivo biocompatibility of TSNs was assessed by histologically
analysing the tissues after applying TSNs or CA-Lp in a
liver puncture model (Fig. 4d and Supplementary Fig. 15).
A significant difference in the level of tissue inflammation was
observed between the biological tissues treated with TSNs and
those with CA-Lp. Consistent with the previous reports, an
immediate immune reaction was identified around the CA-Lp
applied regions within 3 days, and this response developed to a
severe inflammation in and around the adhesives at 14 days, and
persisted over 56 days51. In contrast, the TSN was observed to be
innocuous, which is consistent with the previous report on the
inertness of tantalum54. As the tantalum oxide is a chemically
stable material, the degradation of TSNs is slow compared to that
of polymer adhesives as shown in histological analysis.
The inertness of the tantalum oxide in TSNs was also
supported by the extremely slow dissolution of tantalum in
body fluid (Supplementary Fig. 16). Only little portion spreads to
other organs including liver, spleen, and lung, and most of
the nanoparticles (499.5%) remains in the applied position
(Supplementary Fig. 17). Over six weeks, there was no adverse
effect in our blood test, proving their long-term biocompatibility
in vivo (Supplementary Fig. 18). Considering the intracorporeal
use of adhesives for image-guided procedures, their low cellular
toxicity, low inflammatory reaction derived from the chemical
stability of oxides, and proved long-term biocompatibility can be
crucial advantages over CA-Lp.
Real-time image-guided procedures. To investigate the potential
of TSNs for image-guided surgery, we conducted two surgical
demonstrations to show their utility not only as an adhesive for
medical intervention with real-time imaging modalities but also
as an anatomical marker to guide resection and/or radiotherapy.
The liver puncture model was performed in a rabbit
without abdominal incision under the guidance of fluoroscopy
and ultrasonography (Fig. 5a–d, Supplementary Fig. 19 and
Supplementary Movie 1). Using dynamic X-ray fluoroscopic
imaging, we could distinguish TSNs from other organs including
vertebrae, in spite of low X-ray energy and short exposure time
(60 kV and 1 ms, respectively). In ultrasonography, the TSNs that
filled the liver track appeared as a bright area. Moreover, there
was no bleeding through and on the skin, indicating successful
hemostasis of connective tissues and dermal wounds. Thus,
TSNs can support minimally invasive real-time procedures with
their greatly enhanced contrast effect, enabling both multimodal
imaging capability and adhesive property.
In addition to the potential of TSNs as a tissue adhesive, TSNs
were also applied as a surgical marker (also called as a fiducial
marker) in image-guided procedures. In image-guided procedures
or radiotherapy, the movement of soft tissues often hinders
localizing and registering an operative region. Some metal-based
solid implants, such as a small gold rod or coil, have been used
as markers of soft tissues11. However, their large physical
dimensions usually require complicated insertion procedures
that increase the risk of adverse events57, and those solid implant
markers usually cause streaking artifacts in CT imaging58.
Although injectable liquid fiducial markers have been proposed,
their unwanted migration can lead to serious localization errors
as well as complications in distant tissues. To compare mobility,
five different fiducial markers including TSNs, gold rod, metal
coil, Lipiodol and CA-Lp were implanted in calf lung and liver
samples ex vivo and these samples were subsequently shaken and
CT images are compared. Unlike other materials which generated
strong artifacts (gold rod, metal coil) or which moved substantially
(Lipiodol), TSNs were immobile during the experiment and
caused only negligible artifacts on CT imaging (Fig. 5e,f, and
Supplementary Fig. 20). TSNs are ideal fiducial markers due to
their detectability by various imaging modalities and their strong
adhesion to soft tissues. Moreover, for optical imaging, the
fluorescent dye molecules conjugated on TSNs can prevent the
rapid dye diffusion that usually results in the blurring of injection
sites.
To check the reliability of the TSNs as a fiducial marker within
actively moving tissues, TSNs were injected into the thigh and calf
muscles of rats. The injected TSNs could be clearly visualized by
CT and fluoroscopy, and their positions and shapes were retained
during the flexion and extension of the leg (Fig. 5g,h,j and
Supplementary Movie 2). Micro-CT images showed that the
locations of the TSN markers did not change over two weeks
(Supplementary Fig. 21). In addition, TSNs in the muscle were
readily detected by fluorescence imaging (Fig. 5i), which can help
surgeons recognize a surgical target and perform a safe and
accurate operation59.
Finally, the feasibility of the TSN marker was evaluated with a
rat model of syngeneic lung cancer. Fiducial markers are generally
required for successful resection and radiotherapy of lung cancer,
but its placement in the lung is challenging because of risks such
as migration and distant embolism via the pulmonary veins60,61.
Localizing and marking of target lesions with rhodamine-attached
TSNs were conducted with the aid of CT (Supplementary Fig. 22).
Neither abnormal breathing nor behaviour was observed during
and after the procedures. TSNs were clearly identified in the index
tumours on both fluoroscopy and CT (Fig. 5k,l). The opacity of
TSNs was high enough to be clearly distinguished from the
nearby ribs and vertebrae of the rat. After thoracic incision,
fluorescence signals of the rhodamine-attached TSNs were clearly
observed from the lesion (Fig. 5m). Both the radiopacity of the
TSNs and the high fluorescent signal from rhodamine would help
in guiding the resection of the lesion. Considering that the leg and
lung move vigorously by the physiological motion of rats, the
retention of TSNs represents their great potential as a fiducial
marker.
Discussion
Due to the recent development of medical imaging techniques
and interventional devices, many surgeries have been aided by
image-guided and minimally-invasive procedures. For example,
conventional surgeries for vessel occlusion, bleeding control,
internal organ biopsy, spondylosis, and some early-stage tumours
(for example, hepatocellular carcinoma) are being replaced
by percutaneous angioplasty, catheter-directed embolotherapy,
needle biopsy, vertebroplasty and radiofrequency/microwave
ablation, respectively, all of which are conducted under the
guidance of medical imaging.
However, nanomaterials relevant to the image-guided
procedures are rarely suggested for use in medical practice.
Ideally, they should be identifiable on clinical imaging
(for example, X-ray fluoroscopy, CT, US and magnetic resonance
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imaging), convenient to apply percutaneously with a catheter or
needle, biocompatible to minimize adverse reactions in body, and
able to achieve surgical goals (for example, hemostasis, tissue
adhesion and tissue marking). Given the unique possibilities of
nanomaterials, including high image contrasting effects, adhesive
properties, and dispersibility in various fluids, biocompatible NPs
have enough potential to replace the conventional materials used
in image-guided procedures. In this context, TSNs can be a
representative material that satisfies various requirements for
medical applications by providing imaging capability, convenient
administration, biocompatibility, and effectiveness.
The inertness of tantalum oxide not only provides good
biocompatibility, but also hinders its biodegradation in body.
Unlike typical imaging studies by systemic intravenous
administration of contrast agents, image-guided procedures
usually require a very small quantity of NPs. Compared with
the required amount of tantalum used as an intravenous CT
contrast agent (840 mg kg 1)41, our study utilized less than
one fiftieth of tantalum (15 mg kg 1), which accounted for only
0.02–0.05 ml. Moreover, almost all TSNs are remained in the
target areas without severe adverse reactions, suggesting that the
systemic effects of TSNs can be minor, when administered locally
with image guidance.
As a fiducial marker before a surgery, poor biodegradability
hardly causes a problem because both the index tumour and the
marker will be removed all together (en bloc). In radiotherapy,
persistent marking of an index tumour facilitates the consistent
targeting and follow-up during serial treatments. As a non-
degradable tissue adhesive and a fiducial marker, TSNs exhibit
substantially ameliorated inflammatory reactions compared with
the clinical adhesive mixture, CA-Lp.
In conclusion, we designed and synthesized multifunctional
and biocompatible tantalum oxide/silica core/shell nanoparticles
(TSNs) composed of radiopaque tantalum oxide core with
multimodal imaging capability and silica shell with a strong
tissue adhesive property. As designed, the TSN glue is clearly
visualized by clinical imaging modalities including X-ray fluoro-
scopy, CT, and ultrasonography and exhibits adhesive property
similar to that of the CA-Lp. Furthermore, the TSNs cause much
less cellular toxicity and less inflammation than the clinically used
CA-Lp, which is very important for intracorporeal use of
adhesives for image-guided procedures. Moreover, we demon-
strated the applications of TSNs to hemostatic adhesive for
minimally invasive procedures and as immobilized marker for
image-guided procedures by combining their multifunctional
characteristics and tissue adhesive property. Given the needs of
various tissue adhesives in medicine, our results give additional
insights on biomedical applications of designed multifunctional
nanoparticles, which can be expanded to image-guided procedure
and regenerative medicine as well as drug delivery and cancer
diagnosis.
Methods
Preparation of TSNs. The TSNs were synthesized by the aqueous sol-gel reaction
confined in reverse-micelles based on the previous report41. Igepal CO-520 (46 g,
Sigma-Aldrich), ethanol (5 ml, Samchun, 99.9%), aqueous NaOH solution (5 ml,
150 mM, Samchun) were mixed with cyclohexane (800 ml, Samchun, 99.5%) to
form a microemulsion under vigorous stirring. To the resulting transparent
solution, tantalum ethoxide (1 ml, 3.85 mmol, Strem, 99.8%) was injected at room
temperature, and stirred for 30 min. Subsequently, 28% ammonium hydroxide
solution (5 ml, Samchun) and tetraethyl orthosilicate (TEOS, 1 ml, 4.47 mmol,
Acros, 98%) were successively added. The mixture was stirred at room temperature
for 12 h. After the reaction, the solvents were removed by evaporation at 60 C,
until the solution became white and viscous. The synthesized nanoparticles were
separated by centrifugation, and dispersed in ethanol. To remove the adsorbed
surfactants, 5 ml of hydrochloric acid (Daejung, 35%) was added, and the
nanoparticles were centrifuged and subsequently washed with ethanol twice. The
solution was neutralized by washing twice each with 20 ml of phosphate buffer
(pH¼ 8.0, 0.1 M) and distilled water. Finally, the solution was concentrated up to
40 wt% and loaded into a 1-ml syringe.
Rhodamine conjugation and surface modification of the TSNs. The conjugation
of TSNs was performed by mixing acid-treated nanoparticles with dye-conjugated
silane. Tetramethylrhodamine isothiocyanate (0.44 mg, Sigma-Aldrich, mixed
isomers) and (3-aminopropyl)trimethoxysilane (0.18 mg, Sigma-Aldrich, 97%)
were dissolved in 0.5 ml of dimethylformamide (Samchun, 99.5%), and the solution
was shaken gently for 30 min. The resulting dye solution was added to the
nanoparticle solution dispersed in the phosphate buffer (pH¼ 8.0), and kept
being shaken over 8 h. The unreacted dye molecules were removed by several
centrifugations, and the resulting nanoparticles were dispersed in distilled water.
Other surface modification details were summarized in Supplementary Table 1.
Preparation of CA-Lp and SiO2 NPs. CA-Lp was prepared by mixing Histoacryl
(B.Braun Surgical, Germany) and Lipiodol Ultra-Fluid (Guerbet, France) with a
volumetric ratio of 1:3, to have a comparable fluoroscope contrast effect, with the
iodine concentration of 360 mg ml 1. CA-Lp was prepared right before the
experiments to avoid the loss of the adhesive properties. To make a comparison
with the reported nano-bridging SiO2 NPs, Ludox TM-50 (50 wt% of silica) was
purchased from Sigma-Aldrich and used without any treatment19,20.
Characterization of TSNs and SiO2 NPs. TSNs and SiO2 NPs were characterized
using a TEM (200 kV, JEOL-2,100, JEOL Ltd., Japan) equipped with an electron
energy loss spectroscopy mapping (EELS, Quantum 963, Gatan, Inc., USA) and
energy-dispersive X-ray spectroscopy (EDS, X-MAX 80T, Oxford). High-resolution
HAADF-STEM images were obtained with Cs-corrected STEM (200 kV,
JEM-ARM200F, JEOL Ltd., Japan) of National center for inter-university research
facilities, Seoul National University. For EDS analysis, due to energy overlap
between Si Ka and Ta Ma (Si Ka¼ 1.739 eV, Ta Ma¼ 1.709 eV), the energy range
for Ta signal was set to 9.15–9.80 eV to include Ta Lb1 (9.343 eV) and Lb2
(9.651 eV). Fourier transform infrared (FT-IR) spectra were obtained with a JASCO
FT/IR-200 (Jasco, Inc., Japan). Hydrodynamic diameters and z-potentials of the
nanoparticles dispersed in water were analysed with a size analyser (Nanozs,
Malvern, Germany). The absorption and emission spectra of the rhodamine-
conjugated nanoparticles and free dye were measured with a SpectroV-550
(Jasco Inc.) and a FP-5,500 (Jasco Inc.). Nitrogen adsorption/desorption isotherm
was measured by a 3FLEX surface characterization analyzer (Micromeritics, USA).
Evaluation of contrast effect. Each type of the adhesive (TSNs, SiO2 NPs and
CA-Lp) was loaded into a 2-ml tube. The contrast effect on fluoroscopy was
measured with images acquired by an Allura Xper FD20 (Philips, Netherlands,
at 80 kV of tube voltage). The SNR was calculated as SNR¼ S/N, where S is the
mean attenuation of each material and N is the s.d. of background attenuation.
Dose-dependent contrast enhancement was examined by comparing the TSNs
with SiO2 NPs (Ludox TM-50) and a contrast agent (iopamidol, Pamiray,
Dongkook pharmaceutical Co., Korea) which were prepared with the same mass
concentration. The solutions containing the nanoparticles or the contrast agent
were diluted sequentially and dispersed in 1 wt% agarose gel and loaded to 200 ml
microtubes. Both fluoroscopy and CT were used to analyse these series of tubes,
and the obtained images were evaluated with the OsiriX software (version 4.0;
32 bit; OsiriX foundation Geneva). The clinical CT scanner (Brilliance 64, Philips
Medical System, USA) was operated at 140 kVp and 150 mA. To compare the
US contrast effect of the TSNs with other glues, 50 ml of each glue was injected to
fresh calf liver using an 18-gauge needle while withdrawing a syringe. Afterwards,
B-mode US images were obtained with an Accuvix V10 (Samsung Medison co.,
Ltd, Korea). The mean intensity and s.d. of each region-of-interest were calculated
with the ImageJ software (version 1.48v, NIH). To evaluate the contrast effect in
serial dilution, the SiO2 NPs and TSNs were diluted using 1 wt% agarose, and
200 ml of each solution were cured in a 96-well plate. The plate was immersed in a
water bath and the backscattered amplitudes were measured with the same method
used in the calf specimens.
Adhesion strength test. Fresh calf livers purchased from local meat shop
(Yuchang Sik-pum, Geumcheon-gu, Seoul, Korea) were cut into several pieces of
ribbon shape (45 mm 10 mm 4 mm each) with a scalpel and an autopsy blade.
Two pieces of the calf liver ribbons were adhered by applying B15ml of each glue.
The ribbon pieces were overlapped by 10 mm, and the overlapped portion was
gently pressed by a finger for 10 s. To quantify the adhesive strength of the
lap joints attached by the glues, lap-shear tests were performed by using an
Instron-5,543 electromechanical system (Instron, USA) controlled by the Bluehill
software (Ver. 3). The lab joints were placed in a 50 N load cell and the test was
performed at a speed of 30 mm min 1. Each displacement-force curves were
calibrated to the points after slipping, not to be influenced by weights of the lower
ribbon of liver.
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Electron microscopic imaging of liver tissue. Electron microscope samples
were prepared by fixation and dehydration of the calf liver tissues attached with
TSNs. The adhered tissues were fixed with 2.5% of glutaraldehyde and 2% of
paraformaldehyde in 0.1 M of sodium cacodylate buffer (pH 7.4), which was then
rinsed with cacodylate buffer. Additional fixation was proceeded with 1% osmium
tetraoxide solution in cacodylate buffer. After washing the residual fixation reagent
with distilled water three times, they were stained overnight with 2% uranyl acetate
solution. The dehydration was proceeded gradually with ethanol, by incubating
them for 10 min in 30%, 50%, 70%, 80%, 90% ethanol, and finally absolute ethanol
three times to eliminate water in the tissues. For SEM sample, the tissues were dried
with critical point drier (EM CPD 300, Lieca, Austria) and coated with Pt by
sputter coater (EM ACE200, Leica, Austria). For TEM samples, Spurr’s resin was
used to ultramicrotome sectioning. Further solvent exchange and infiltration of the
resin were proceeded by incubating the dehydrated tissues in propylene oxide twice
for 10 min, in 50% Spurr’s resin with propylene oxide for 2 h, and finally in Spurr’s
resin overnight. The tissues were embedded in fresh Spurr’s resin at 60 C for 24 h.
The embedded samples were cut with ultramicrotome (EM UC7, Leica, Germany).
SEM images were obtained with JSM-6701F (JEOL Ltd.) and energy dispersive
X-ray spectrometer (EDS) spectra and element mapping were performed using the
attached INCA Energy (Oxford Instruments Analytical Ltd., UK). TEM images
were obtained with JEM1010 (JEOL Ltd.).
Cell culture. HeLa cells (HeLa cell-line, human adenocarcinoma, KCLB-10002)
obtained from Korean Cell Line Bank (KCLB, Seoul, Korea) were maintained
in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco). A mycoplasma
contamination check was not carried out. The medium was supplemented with
10% fetal bovine serum (FBS, Gibco BRL), 100 mg ml 1 streptomycin, and 100 IU
penicillin (Gibco BRL). Cells were grown as monolayer cultures in a T75-flask and
sub-cultured three times in one week at 37 C in atmosphere containing 5% CO2
and 100% relative humidity.
Morphological analysis. A 20-ml drop of TSNs or CA-Lp was placed on the
middle of coverglass-bottom dish. A Cell suspension in a logarithmic growth phase
was added to the dish. Following 24 h of cell seeding onto the dish, bright field
images were taken by an inverted confocal microscope (LSM 780, Carl-Zeiss,
Germany).
Viability assay. For the in vitro cytotoxicity assay, cells in a logarithmic growth
phase were detached and plated (400 ml per well) in 24-well flat-bottom microplates
at a density of 40,000 cells per well, which were then left for 24 h at 37 C to resume
exponential growth. After 24 h of recovery, the cellular media were exchanged with
the media containing TSNs with various concentrations. As CA polymerizes and
hardens with water contact, it is hard to be diluted in PBS or cellular media.
Alternatively, we put a drop of CA-Lp gel in the well, letting some molecules or
materials be dissolved naturally and affect the cells. After the removal of the media
in wells, different volume of CA-Lp (100, 200, 400, and 800ml) and different
concentrations of TSNs were introduced to each culture well, and incubated
with 1 ml of cellular media. Following 24 h exposure of the glues to the cells
under the same culturing condition, cell viability was assessed by MTT (3-[4,5-
dimethylthialzol-2-yl]-2,5-diphenyltetrazolium bromide, Sigma) assay. The assay
was performed in quadruplicate in the following manner. The cells were incubated
in media with 1 mg ml 1 of MTT solution for 2 h. Then the MTT solution
was removed and the precipitated violet crystals were dissolved in 1 ml
dimethylsulfoxide (DMSO). The absorbance of the solution was measured at
490 nm with microplate reader (Victor X4, Perkin-Elmer, USA).
Preparation of SiO2 NPs and TaOx NPs for hemolysis test. The 105 nm-sized
SiO2 NPs were synthesized with Stöber process, and 22 nm-sized SiO2 NPs were
prepared with the same microemulsion method used in the preparation of TSN,
except that the precursor was changed to tetramethyl orthosilicate. The 120 nm-
sized TaOx NPs were synthesized by aqueous sol-gel reaction of Ta(OEt)5 in 90%
ethanol aqueous solution.
Animal study. Ethical approval for all living animal and animal part (for example,
isolated tissue, body fluid) experiments was obtained from the Institutional
Animal Care and Use Committee (IACUC) of the Clinical Research Institute of
Seoul National University Hospital (approval number: 13-0197-C1A0), and the
investigators thoroughly followed the IACUC and Association for Assessment and
Accreditation of Laboratory Animal Care International guidelines.
Hemolysis assay. Rabbit blood was collected freshly and stabilized with sodium-
heparin. To remove plasma from the whole blood, 4 ml of whole blood was diluted
with 12 ml of PBS and centrifuged at 10,000 r.p.m. for 5 min. The supernatant
including plasma was removed carefully, and the cells were suspended with
additional 12 ml of PBS. Red blood cells (RBC) were isolated by several washing
process with 12 ml of PBS and the final solution was diluted with 40 ml of PBS. The
nanoparticle solution was diluted with PBS to the various concentrations, and
prepared in triplicate. To assess the hemolysis effect, 0.8 ml of the nanoparticle
solution and 0.2 ml of the diluted RBC suspension were mixed to reach the final
particle concentrations of 100, 200, 500, 1,000 mg ml 1. For negative and positive
controls, PBS and distilled water were mixed with the same amount of RBC,
respectively. The mixtures were incubated at room temperature for 24 h, followed
by a centrifugation at 10,000 r.p.m. for 5 min. Each 200 ml of the supernatant of the
mixture were conveyed to a 96-well plate and its absorbance was measured at
490 nm with a microplate reader. The percentage of the hemolysis of RBCs was
calculated by following formula: percent of hemolysis¼ ((sample absorbance—
negative control absorbance)/(positive control absorbance—negative control
absorbance)) 100.
Degradation experiments of TSN in simulated body fluid. The simulated body
fluid (SBF) was prepared as previous report62. Each 500 ml of SBF was prepared in
polyethylene bottle TSN was immersed with concentration of 200 mg l 1, and
400 mg l 1. About 10 ml of the sample solutions were extracted each time with
centrifugal filter unit (Amicon, 3 kDa). The concentration of free tantalum were
determined using inductively coupled plasma mass spectrometry (Elan 6,100,
PerkinElmer) of National center for inter-university research facilities, Seoul
National University.
Migration experiments for various fiducial markers. Five different markers such
as a contrast agent (Lipiodol), adhesive mixture (CA-Lp), coil, gold rod, and TSNs
were implanted or injected into calf liver and lung specimen. The calf liver and lung
purchased from local meat shop were prepared freshly by cutting into proper sized
cuboid and put into airtight containers. Fifteen needles were attached uprightly to
hold the specimens in the containers. Those were imaged with a CT scanner after 1,
3, 5 and 10 h of shaking. The migration distances were measured according to the
method of a previous report63.
Liver puncture model in SD rat. Ten male SD rats, at the age of 12 weeks, initially
weighing about 400 g, were randomly divided by two groups (that is, five rats per
group) and each group was treated by TSNs and CA-Lp. The rats were anesthetized
by intramuscular injection of a mixture of zolazepam (5 mg kg 1, Zoletil, Virbac,
Carros, France) and xylazine (10 mg kg 1, Rompun, Bayer-Schering Pharma,
Berlin, Germany). To apply the glues to the rat liver and to evaluate their
hemostatic effect, the left lobe of the liver of was exposed by a median abdominal
incision. After creating a liver stab wound, 18-gauge in diameter (1.27 mm) and
1.5 cm in length, the needle track was closed with TSNs or CA-Lp mixture pre-
loaded within a syringe. 0.03 ml of the adhesives was slowly injected during the
withdrawal of the needle. To measure the amount of bleeding, hydrophobic films
(Parafilm) were put on each lower and upper side of the liver and filter paper was
put right onto the wound area. After bleeding stopped, the amount of the absorbed
blood was calculated by measuring the change of the weight of the filter papers.
CT and fluoroscopy images were acquired after the abdominal closure.
Fluoroscopic images were obtained with exposure of X-ray at 80 kV for 3 ms.
CT imaging parameters of the SD rats were as followed: thickness, 0.6 mm; pitch,
0.648; 120 kVp, 300 mA; field of view, 127 127; gantry rotation time, 0.75 s; table
speed, 16.7 mm s 1.
Image-guided procedure in a rabbit liver puncture model. Demonstration of
image-guided procedures was conducted with a male New Zealand White rabbit
weighing 3.5 kg, with the same method in SD rats, except the abdominal incision
and exposure of the liver. An 18-gauge stainless steel needle was used to make an
intrahepatic track under the guidance of US and fluoroscopy, and 0.05 ml of the
adhesives was slowly injected during the withdrawal of the needle. During the
image-guided procedure, the operation video and fluoroscopy video were recorded
simultaneously. The fluoroscopic images were acquired with exposure of X-ray at
60 kV for 1 ms.
Percutaneous anatomical marking in rats. Regarding the clinical contexts where
fiducial marking for subsequent image-guided surgery or radiotherapy is frequently
used (that is, musculoskeletal tumours and lung tumours), experiments were
conducted for the leg muscles and syngeneic lung tumour. The muscle and lung
marking studies were conducted with two male SD rats (12-week-old, 400 g) and
two male F344 rats (12-week-old, 300 g), respectively. Regarding the muscular
injection study, 0.02 ml of TSNs was gently implanted into the thigh and calf
muscles of male SD rats though a 22-gauge needle. The fiducial markers were
observed on micro-CT, real-time fluoroscopy, and fluorescent imaging (IVIS 100,
Perkin Elmer). During the fluoroscopic study, the TSN-implanted leg was manually
flexed and extended to address whether the fiducial marker was changed in its
shape and/or position. To obtain fluorescent signals from the deep muscles, the legs
were skinned before fluorescent imaging. For creating a syngeneic lung cancer
model, a 0.5 0.5 0.5 cm sized tumour chip (13762-MAT-B-III cell-line
(CRL-1666, ATCC, Manassas, VA, USA)) was injected into the tail vein of
male F344 rats. After 10 days, the rats underwent a CT study to identify lung
embolization and growth of the tumour chip. A 25-gauge needle was precisely
advanced to the lung tumour under CT imaging guidance, and then 0.02 ml of
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pre-loaded TSNs was slowly injected into the target. The markers were also
observed on CT, real-time fluoroscopy, and fluorescent imaging that obtained after
thoracostomy.
Histological analysis. The rats were killed in a CO2 chamber, and then the liver
was excised and fixed in 10% neutral buffered formalin (10% NBF) for one week.
For hematoxylin and eosin (H&E) staining, formalin fixed tissues from each
specimen were embedded into paraffin and sectioned into 4 mm thickness. Standard
H&E staining was performed to evaluate morphological features of each specimen
regarding inflammatory reactions and fibrosis as time passes. Afterwards, all
samples were digitalized with optical magnification ( 200) to conduct further
analyses. The slides were carefully reviewed by an experienced pathologist who was
blinded to the kinds of adhesives.
In vivo toxicity evaluation of TSN. To assess the in vivo toxicity of the TSNs,
serum chemistry and biodistribution of the NPs were evaluated. 30 ml of the TSNs
solution and CA-Lp mixture was applied to SD rats. Since we are interested in two
different regions of application, rats were divided into two groups; one is for the
liver and the other is for muscle. Rats were killed after 3, 7, 28 and 42 days from the
nanoparticle application, and the reticuloendothelial system (liver, spleen and
kidney), blood, heart, muscle and lung were collected. In the target organ (liver and
muscle), two different regions within the same organ were collected. The tissues
were firstly digested with nitric acid, and hydrofluoric acid was added to dissolve
TSNs. Ta concentration was determined from inductively coupled plasma mass
spectrometer (ICP-MS, NexION300, Perkin Elmer, USA). By collecting 2-ml blood
samples from the tail vein of the SD rats, serum biochemistry was examined from
the analysis for inflammation (CRP), liver function (ALP, AST and ALT), and
kidney function (BUN, CREA), at 3, 7, 21 and 42 days after application of TSN to
liver and muscle.
Statistical analysis. Statistical analyses of intergroup comparisons were
performed using one-way ANOVA test with Tukey post hoc analysis, or two-way
ANOVA test with Bonferroni post hoc anaylsis for experiments having two
variables. Sizes of sample were determined to empirically for sufficient statistical
power. The specific statistical tests and significance level are noted in the figure
captions. For calculation of statistical analysis, computational programs including
Origin 9.0 and GraphPad Prism 5.0 were used. The investigators were not blinded
to group allocations during the experiments and analyses except for the histological
analysis, and no randomization method was used.
Data availability. Data supporting the findings of this study are available within
the article and its Supplementary Information Files and from the corresponding
author on reasonable request.
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